PAL News Alert North American Palladium (PAL) 0.14 01/06/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
North American Palladium (PAL) 0.14 $PAL

The Concept Of AISC In The Gold Mining Industry: Strength And Weakness
Fun Trading - at Seeking Alpha - Tue Jan 06, 6:53AM CST

GORO: 3.72 (+0.27), AEM: 29.03 (+1.58), ABX: 11.27 (+0.37), PAL: 0.14 (+0.01), KGC: 3.33 (+0.38), NEM: 20.27 (+0.81), IAG: 3.25 (+0.23), SWC: 14.61 (+0.06), AUY: 4.48 (+0.46), GG: 20.31 (+1.46)

North American Palladium Down 5.2%, Shares Slide into the Red (PAL)
Comtex SmarTrend(R) - Tue Dec 16, 10:10AM CST
North American Palladium (AMEX AL) is one of today's worst performing penny stocks, down 5.2% to $0.13 on 1.0x average daily volume. North American Palladium has traded 1.9 million shares thus far today, vs. average volume of 1.9 million shares per day. The stock has underperformed the Dow (-6.9% to the Dow's 0.5%) and underperformed the S&P 500 (-6.9% to the S&P's 0.5%) during today's trading.
PAL: 0.14 (+0.01)

North American Palladium 3rd Quarter Results And Commentary
Fun Trading - at Seeking Alpha - Thu Dec 11, 1:17PM CST

PAL: 0.14 (+0.01)

North American Palladium Provides Update on Ramp-Up Progress at Lac des Iles Mine
Marketwired - Thu Dec 11, 5:00AM CST
North American Palladium Ltd. ("NAP" or the "Company" (TSX: PDL)(NYSE MKT: PAL) announces an update for selected operating results for the months of October and November and year to date from the ongoing successful ramp-up of its operations at its Lac des Iles ("LDI" mine in Thunder Bay, Ontario.
PDL.TO: 0.17 (+0.02), PAL: 0.14 (+0.01)

Analyst Scanner on Metals and Mining Equities - Cliffs Natural Resources, North American Palladium, Pan American Silver, BHP Billiton, and Hi-Crush Partners
PR Newswire - Mon Dec 08, 8:15AM CST
Investor-Edge has initiated coverage on the following equities: Cliffs Natural Resources Inc. (NYSE: CLF), North American Palladium Ltd (NYSE MKT: PAL), Pan American Silver Corporation (NASDAQ: PAAS), BHP Billiton Ltd (NYSE: BHP), and Hi-Crush Partners L.P. (NYSE: HCLP). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, December 05, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,958.79, up 0.33% and the NASDAQ Composite closed at 4,780.76, up 0.24%. The S&P 500 finished the session 0.17% higher at 2,075.37. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Materials Sector Index ended the day at 311.67, down 0.11%, whereas the index has advanced 1.92% in the last one month. Register for your complimentary reports on these five stocks at:
BHP: 45.56 (-0.29), PAL: 0.14 (+0.01), HCLP: 29.30 (-0.83), PAAS: 10.24 (+0.35), CLF: 6.31 (-0.21)

Hot Stock: North American Palladium, Shares Gain 8.1% (PAL)
Comtex SmarTrend(R) - Tue Nov 25, 10:09AM CST
North American Palladium (AMEX AL) is one of today's best performing penny stocks, up 8.1% to $0.15 on 1.3x average daily volume. North American Palladium has traded 2.9 million shares thus far today, vs. average volume of 2.2 million shares per day. The stock has outperformed the Dow (9.6% to the Dow's -0.1%) and outperformed the S&P 500 (9.6% to the S&P's -0.1%) during today's trading.
PAL: 0.14 (+0.01)

The Turnaround Story At North American Palladium Is Growing Legs
David White - at Seeking Alpha - Mon Nov 24, 2:17PM CST

PAL: 0.14 (+0.01), CAT: 86.47 (-0.56)

North American Palladium Third-Quarter Results And Commentary
Fun Trading - at Seeking Alpha - Mon Nov 10, 5:00AM CST

PAL: 0.14 (+0.01)

North American Palladium's (PAL) CEO Philippus F. Du Toit on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 4:40PM CST

PAL: 0.14 (+0.01)

Investors look to Lighten Up on Shares of North American Palladium, Shares Down 8.1% (PAL)
Comtex SmarTrend(R) - Wed Nov 05, 11:38AM CST
North American Palladium (AMEX AL) is one of today's worst performing penny stocks, down 8.1% to $0.16 on 1.0x average daily volume. North American Palladium has traded 2.2 million shares thus far today, vs. average volume of 2.2 million shares per day. The stock has underperformed the Dow (-8.7% to the Dow's 0.5%) and underperformed the S&P 500 (-8.7% to the S&P's 0.4%) during today's trading.
PAL: 0.14 (+0.01)

North American Palladium misses by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 8:09AM CST

PAL: 0.14 (+0.01)

North American Palladium Announces Third Quarter 2014 Results
Marketwired - Wed Nov 05, 6:03AM CST
North American Palladium Ltd. ("NAP" or the "Company" (TSX: PDL)(NYSE MKT: PAL) today announced the operating, development, and financial results for the third quarter ended September 30, 2014 ("Q3" .
PDL.TO: 0.17 (+0.02), PAL: 0.14 (+0.01)

Technical Data on Metals and Mining Stocks - North American Palladium, Endeavour Silver, Pan American Silver, Horsehead Holding, and Hi-Crush Partners
PR Newswire - Tue Oct 28, 8:10AM CDT
Investor-Edge has initiated coverage on the following equities: North American Palladium Ltd (NYSE MKT: PAL), Endeavour Silver Corporation (NYSE: EXK), Pan American Silver Corporation (NASDAQ: PAAS), Horsehead Holding Corporation (NASDAQ: ZINC), and Hi-Crush Partners LP (NYSE: HCLP). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, October 27, 2014, mostly ended on a positive note as the Dow Jones Industrial Average finished at 16,817.94, up 0.07% and the NASDAQ Composite closed at 4,485.93, up 0.05%. The S&P 500 finished the session 0.15% lower at 1,961.63. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Materials Sector Index ended the day at 297.60, down 2.06%, whereas the index has advanced 2.04% on YTD basis. Register for your complimentary reports on these five stocks at:
ZINC: 14.70 (-0.21), PAL: 0.14 (+0.01), HCLP: 29.30 (-0.83), PAAS: 10.24 (+0.35), EXK: 2.49 (+0.10)

eResearch Posts Market Timing Technical Commentaries for Wednesday, October 22
ACCESSWIRE - Wed Oct 22, 9:36AM CDT
Toronto, ON / ACCESSWIRE / October 22, 2014 / eResearch posts daily two market timing technical commentaries, courtesy of Don Vialoux of the Tech Talk Financial Network. eResearch is pleased to be given permission to distribute these astute and thoughtful newsletters.
PAL: 0.14 (+0.01)

Stock to Watch: North American Palladium Up 9.3% (PAL)
Comtex SmarTrend(R) - Mon Oct 20, 12:42PM CDT
North American Palladium (AMEX AL) is one of today's best performing penny stocks, up 9.3% to $0.15 on 1.0x average daily volume. Thus far today, North American Palladium has traded 2.3 million shares, vs. average volume of 2.3 million shares per day. The stock has outperformed the Dow (9.3% to the Dow's -0.1%) and outperformed the S&P 500 (9.3% to the S&P's 0.6%) during today's trading.
PAL: 0.14 (+0.01)

North American Palladium to Host Third Quarter 2014 Results Conference Call & Webcast on November 5, 2014
Marketwired - Fri Oct 17, 7:02AM CDT
North American Palladium Ltd. ("NAP" (TSX: PDL)(NYSE MKT: PAL) will host a conference call and live webcast with its management team on Wednesday, November 5, 2014 at 8:30 a.m. ET to discuss NAP's third quarter ended September 30, 2014 financial and operating results.
PDL.TO: 0.17 (+0.02), PAL: 0.14 (+0.01)

North American Palladium Reports Third Quarter Drilling Results for Lac des Iles
Marketwired - Thu Oct 16, 7:06AM CDT
North American Palladium Ltd. ("NAP" or the "Company" (TSX: PDL)(NYSE MKT: PAL) is pleased to announce third quarter drilling results from its 2014 Lac des Iles exploration program. Highlights include encouraging results from the ongoing extension and conversion drilling program targeting the Lower, North and Upper parts of the Offset Zone. In addition, surface drilling completed in the third quarter outlined a new zone (the "Powerline Zone" of high-grade mineralization exposed at surface, adjacent to the Roby Zone open pit.
PDL.TO: 0.17 (+0.02), PAL: 0.14 (+0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 1

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Aterian Prepares for Upcoming Earnings Call This Quarter

Updated Category News Views 99

Aterian's Upcoming Financial Results Announcement Aterian, Inc. (Nasdaq: ATER), a prominent player in the consumer products sector, is gearing up to reveal its financial performance for the second quarter. Scheduled for Wednesday in the coming week, this announcement will take place after market closure, providing investors with valuable insights into the company’s...

Continue Reading
Analyzing RTX: Trends in Short Interest and Market Sentiment

Updated Category News Views 176

Understanding RTX's Recent Market Movements RTX Corp has seen a notable shift in its market dynamics recently. The company's short interest, defined as the number of shares sold short but not yet covered, has decreased by 7.63% since the last reporting period. Currently, there are approximately 16.18 million shares sold short, equating to 1.21% of all shares available for...

Continue Reading
Celebrate Christmas Spirit with Personalized PrayerSongs

Updated Category News Views 156

Celebrate the Joy of Christmas with PrayerSong Bring Love Into Your Home with a PrayerSong for Your Family and Friends When the holiday season arrives, the focus shifts beyond material gifts. Instead, it’s about nurturing connections filled with love, faith, and meaningful moments. This Christmas, PrayerSong provides families with a unique opportunity to honor loved...

Continue Reading
Understanding the Short Selling Landscape of Analog Devices

Updated Category News Views 153

Analyzing Short Interest for Analog Devices As investors navigate the ever-changing stock market, understanding short interest can provide valuable insights into market sentiment regarding Analog Devices (NYSE: ADI). Recently, it was reported that Analog Devices has seen a notable increase of 4.11% in its short percent of float. Currently, there are approximately 7.52...

Continue Reading
Future of Clinical Trials: Exploring Market Growth to USD 85.37 Billion

Updated Category News Views 71

Understanding Clinical Trials and Their Importance Clinical trials serve as a fundamental pillar in advancing medical knowledge and enhancing patient care. These trials encompass a detailed and thorough process involving participant recruitment, intervention administration, data collection, and result analysis. The outcomes produced from clinical trials play a crucial...

Continue Reading